Anogenital cancers testing in Valtournenche

Find health labs to test for Anogenital cancers in Valtournenche and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Lafarmacia.Cervinia

Via Carrel, 22, 11021 Valtournenche AO, Italia

Unverified

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Laboratorio Lifebrain

Via Piemonte, 32, Strambino, TO, c/o Centro Medico Artemisia 10019 Strambino (TO)

36.2 km

Unverified

See Details

Pap Smear by Ospedale Ss. Trinità Borgomanero

Viale Zoppis, 10, 28021 Borgomanero NO, Italia

42.3 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Valperga Caluso, 32 10125 Torino (TO)

55.6 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Corso Raffaello, 17G 10125 Torino (TO)

55.6 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Piazza Monte Grappa, 12 21100 Varese (VA)

57.9 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Moncucco, 15 21040 Jerago con Orago (VA)

57.6 km

Unverified

See Details

Pap Test by Synlab

Via Alfredo Cappellini, 20, 21013 Gallarate VA, Italia

58.4 km

Unverified

See Details

Pap Smear by Synlab

Via Alfredo Cappellini, 20, 21013 Gallarate VA, Italia

58.4 km

Unverified

See Details

Pap Smear by Studio Medico Mirafiori

Strada Basse del Lingotto, 19, 10127 Torino TO, Italia

55.6 km

Unverified

See Details

Pap Smear by San Carlo Istituto Clinico

Via Castelfidardo, 19, 21052 Busto Arsizio VA, Italia

62.1 km

Verified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.